News

The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...
FDA staff tested Elsa on Monday with questions about FDA-approved products or other public information, only to find that it provided summaries that were either completely or partially wrong.
The FDA’s tool—nicknamed Elsa—is designed to assist employees with everything from scientific reviews to basic operations. Originally, the FDA planned to launch by June 30, ...
The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. The Food and Drug Administration ...
Elsa’s deployment comes ahead of schedule, with the rollout date initially slated for June 30. Leadership at the FDA has been keen to incorporate more AI tools across agency operations following ...
The U.S. Food and Drug Administration (FDA) has launched Elsa, an AI tool designed to modernize and speed up agency-wide operations ranging from scientific reviews to investigations. Marty Makary ...
Elsa’s introduction coincides with the release of President Trump’s 2026 budget proposal (PDF), which for the FDA includes a proposed reduction (PDF) of about 4% to $6.8 billion, including the ...
The FDA will plan to focus Elsa’s scope on administrative tasks such as summarizing documents and data extraction. This is the right approach, according to Panna Sharma, CEO and president of ...
FDA claims victory with "Elsa" AI tool launch, but insiders call it half-baked Employees say FDA's Elsa launch prioritized optics over usability By Cal Jeffrey June 5, 2025, 13:39.
In this edition of STAT's AI Prognosis: FDA's AI tool, Elsa was launched across the agency weeks ahead of shcedule, and more health AI news.